Heparin-induced thrombocytopenia (HIT) is a rare but serious reaction to heparin. It causes low platelet counts & raises clotting risk. Early diagnosis and stopping heparin are crucial.
Thrombophilia
Thrombophilia is an increased tendency to form blood clots. It can be inherited or acquired, raising the risk of DVT, PE, and other thrombotic events. Understanding its causes and management is crucial.
Catastrophic Antiphospholipid Syndrome
Catastrophic Antiphospholipid Syndrome (CAPS) is a rare, severe autoimmune disease causing rapid-onset, widespread blood clotting and multi-organ failure. Prompt diagnosis and aggressive treatment are crucial for survival.

HELLP Syndrome
HELLP syndrome: A serious pregnancy issue with hemolysis, elevated liver enzymes, and low platelets. Requires urgent care.

Lipoprotein(a): The Silent Heart Risk You Need to Know
Lp(a): genetic risk for clots & heart disease. Not lowered by diet. Tests measure levels. Manage other risk factors.

HELLP Syndrome
HELLP syndrome: A serious pregnancy issue with hemolysis, elevated liver enzymes, and low platelets. Requires urgent care.
Fibrinolysis
The process of fibrinolysis dissolves fibrin clots after wound healing, restoring blood flow and preventing unwanted thrombus formation.
Secondary Hemostasis: Coagulation Cascade
Coagulation cascade creates a fibrin mesh that strengthens and stabilizes the platelet plug into a permanent clot.
Primary Hemostasis: The Platelet Plug
A formation of an quick but unstable plug as a first response to stop bleeding. Our very own platelet patch.
Venous Thrombosis (VTE)
Venous thromboembolism: Unilaterla leg pain with lungs at risk. Master Virchow’s triad (stasis, hypercoagulability, injury), recognize DVT & PE, and advocate for early diagnosis & prevention.
Arterial Thrombosis
Heart attacks, strokes, amputations: All linked to one silent threat. Explore the world of arterial thrombosis and learn how to prevent it.
Platelet Aggregation Test (PAT)
Platelet aggregation test: Checking how blood cells clump to form clots using different agonists.